Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Change in Account Payables: 2018-2024

Historic Change in Account Payables for Gossamer Bio (GOSS) over the last 7 years, with Dec 2024 value amounting to -$1.7 million.

  • Gossamer Bio's Change in Account Payables fell 169.49% to -$795,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.5 million, marking a year-over-year decrease of 847.05%. This contributed to the annual value of -$1.7 million for FY2024, which is 141.50% down from last year.
  • As of FY2024, Gossamer Bio's Change in Account Payables stood at -$1.7 million, which was down 141.50% from $4.0 million recorded in FY2023.
  • Gossamer Bio's 5-year Change in Account Payables high stood at $7.0 million for FY2020, and its period low was -$4.4 million during FY2021.
  • Its 3-year average for Change in Account Payables is $173,667, with a median of -$1.7 million in 2024.
  • Its Change in Account Payables has fluctuated over the past 5 years, first skyrocketed by 599.21% in 2020, then tumbled by 163.40% in 2021.
  • Yearly analysis of 5 years shows Gossamer Bio's Change in Account Payables stood at $7.0 million in 2020, then slumped by 163.40% to -$4.4 million in 2021, then soared by 59.06% to -$1.8 million in 2022, then surged by 320.08% to $4.0 million in 2023, then plummeted by 141.50% to -$1.7 million in 2024.